Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Nature Communications
|
August 2, 2020
Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis
Luca Muzio, Riccardo Sirtori, Davide Gornati, et al.
Scientific Reports
|
August 6, 2025
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer
Lorenzo Castagnoli, Francesco Bonì, Martina Bigliardi, et al.
Journal of Medicinal Chemistry
|
June 7, 2021
Synthesis and Characterization of Novel Mono- and Bis-Guanyl Hydrazones as Potent and Selective ASIC1 Inhibitors Able to Reduce Brain Ischemic Insult
Davide Gornati, Roselia Ciccone, Antonio Vinciguerra, et al.
Bioorganic & Medicinal Chemistry
|
October 16, 2012
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization
Daniele Lecis, Eloise Mastrangelo, Laura Belvisi, et al.
British Journal of Haematology
|
October 6, 2004
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'
Andrés J M Ferreri, Elías Campo, John F Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience
Andrés J M Ferreri, Jean-Yves Blay, Michele Reni, et al.
ACS Infectious Diseases
|
August 3, 2024
4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses
Michela Puxeddu, Manuela Donalisio, Joachim Jakob Bugert, et al.
Bioorganic & Medicinal Chemistry
|
July 22, 2009
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy
Pierfausto Seneci, Aldo Bianchi, Cristina Battaglia, et al.
Antiviral Research
|
December 1, 2009
Structure and functionality in flavivirus NS-proteins: perspectives for drug design
Michela Bollati, Karin Alvarez, René Assenberg, et al.
Iscience
|
October 12, 2023
A quinolin-8-ol sub-millimolar inhibitor of UGGT, the ER glycoprotein folding quality control checkpoint
Kevin P Guay, Roberta Ibba, J L Kiappes, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Nature Communications
|
August 2, 2020
Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis
Luca Muzio, Riccardo Sirtori, Davide Gornati, et al.
Scientific Reports
|
August 6, 2025
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer
Lorenzo Castagnoli, Francesco Bonì, Martina Bigliardi, et al.
Journal of Medicinal Chemistry
|
June 7, 2021
Synthesis and Characterization of Novel Mono- and Bis-Guanyl Hydrazones as Potent and Selective ASIC1 Inhibitors Able to Reduce Brain Ischemic Insult
Davide Gornati, Roselia Ciccone, Antonio Vinciguerra, et al.
Bioorganic & Medicinal Chemistry
|
October 16, 2012
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization
Daniele Lecis, Eloise Mastrangelo, Laura Belvisi, et al.
British Journal of Haematology
|
October 6, 2004
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'
Andrés J M Ferreri, Elías Campo, John F Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience
Andrés J M Ferreri, Jean-Yves Blay, Michele Reni, et al.
ACS Infectious Diseases
|
August 3, 2024
4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses
Michela Puxeddu, Manuela Donalisio, Joachim Jakob Bugert, et al.
Bioorganic & Medicinal Chemistry
|
July 22, 2009
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy
Pierfausto Seneci, Aldo Bianchi, Cristina Battaglia, et al.
Antiviral Research
|
December 1, 2009
Structure and functionality in flavivirus NS-proteins: perspectives for drug design
Michela Bollati, Karin Alvarez, René Assenberg, et al.
Iscience
|
October 12, 2023
A quinolin-8-ol sub-millimolar inhibitor of UGGT, the ER glycoprotein folding quality control checkpoint
Kevin P Guay, Roberta Ibba, J L Kiappes, et al.
Page
of 11